PLSE Stock: Price, Earnings History and SEC Filings
Pulse Biosciences, Inc. (PLSE) last traded at $52.24, down 5.84% on the latest session and up 4.6% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-0.36 against an analyst estimate of $-0.31, a miss of 16.1%.
$52.24 -5.84%
1 month+4.65%
52-week high$58.90
52-week low$12.56
Volume466,451
ExchangeNasdaqCM
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
PLSE earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 6, 2026 | $-0.36 | $-0.31 | -16.13% |
| Mar 2026 | May 4, 2026 | $-0.27 | $-0.32 | +15.62% |
| Dec 2025 | Feb 19, 2026 | $-0.26 | $-0.32 | +18.75% |
| Sep 2025 | Nov 5, 2025 | $-0.29 | $-0.31 | +6.45% |
PLSE beat the analyst EPS estimate in 3 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for PLSE
SEC filing data is not available right now. You can search for PLSE on SEC EDGAR.
PLSE news
- DexCom (DXCM) Surpasses Q3 Earnings and Revenue EstimatesOct 29, 2026 · finance.yahoo.com
- Pulse Biosciences stock trades at EUR 48.80 late ThursdayOct 29, 2026 · ad-hoc-news.de
- Pulse Biosciences to Present at Stifel 2026 Healthcare ConferenceOct 29, 2026 · finance.yahoo.com
- Pulse Biosciences (PLSE) Stock Still Seems Rich Against Book ValueOct 25, 2026 · finance.yahoo.com
- Pulse Biosciences Schedules Third Quarter 2026 Financial Results Conference Call for November 5, 2026Oct 22, 2026 · finance.yahoo.com
About Pulse Biosciences, Inc.
Pulse Biosciences, Inc. (PLSE) is a US-listed public company on Nasdaq.